Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor-positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?

Nigro O, Marrazzo C, Gallerani E, Bascialla L, Gueli R, Grigioni E, De Giorgi A, Giaquinto A, Vallini I, Pinotti G.

Anticancer Drugs. 2020 Jan 31. doi: 10.1097/CAD.0000000000000904. [Epub ahead of print]

PMID:
32011361
2.

On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study.

Bolzacchini E, Pinotti G, Bertù L, Verusio C, Galli L, Mumoli N, Barbara C, Danova M, Bregni M, Artale S, Rossini C, Nigro O, Antonuzzo A, Derosa L, Torchio M, Barzaghi S, Ricci I, Suter M, Ballerio A, Vallini I, Dentali F.

Clin Genitourin Cancer. 2019 Dec 5. pii: S1558-7673(19)30307-6. doi: 10.1016/j.clgc.2019.10.003. [Epub ahead of print]

PMID:
31889670
3.

EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing.

Lettig L, Sahnane N, Pepe F, Cerutti R, Albeni C, Franzi F, Veronesi G, Ogliari F, Pastore A, Tuzi A, Pinotti G, Bovio A, Verusio C, Giordano M, Troncone G, Sessa F, Malapelle U, Furlan D.

Transl Lung Cancer Res. 2019 Oct;8(5):584-592. doi: 10.21037/tlcr.2019.09.18.

4.

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.

Pagani O, Francis PA, Fleming GF, Walley BA, Viale G, Colleoni M, Láng I, Gómez HL, Tondini C, Pinotti G, Di Leo A, Coates AS, Goldhirsch A, Gelber RD, Regan MM; SOFT and TEXT Investigators and International Breast Cancer Study Group.

J Clin Oncol. 2019 Oct 16:JCO1801967. doi: 10.1200/JCO.18.01967. [Epub ahead of print]

PMID:
31618131
5.

Biological effects of verbascoside and its anti-inflammatory activity on oral mucositis: a review of the literature.

Nigro O, Tuzi A, Tartaro T, Giaquinto A, Vallini I, Pinotti G.

Anticancer Drugs. 2020 Jan;31(1):1-5. doi: 10.1097/CAD.0000000000000818.

PMID:
31609769
6.

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.

Cazzaniga ME, Pinotti G, Montagna E, Amoroso D, Berardi R, Butera A, Cagossi K, Cavanna L, Ciccarese M, Cinieri S, Cretella E, De Conciliis E, Febbraro A, Ferraù F, Ferzi A, Fiorentini G, Fontana A, Gambaro AR, Garrone O, Gebbia V, Generali D, Gianni L, Giovanardi F, Grassadonia A, Leonardi V, Marchetti P, Melegari E, Musolino A, Nicolini M, Putzu C, Riccardi F, Santini D, Saracchini S, Sarobba MG, Schintu MG, Scognamiglio G, Spadaro P, Taverniti C, Toniolo D, Tralongo P, Turletti A, Valenza R, Valerio MR, Vici P, Clivio L, Torri V; VICTOR Study Group.

Breast. 2019 Dec;48:7-16. doi: 10.1016/j.breast.2019.07.006. Epub 2019 Aug 22.

PMID:
31470257
7.

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B.

J Clin Oncol. 2019 Jul 1;37(19):1629-1637. doi: 10.1200/JCO.18.01779. Epub 2019 Apr 11.

8.

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.

Di Bartolomeo M, Niger M, Morano F, Corallo S, Antista M, Tamberi S, Lonardi S, Di Donato S, Berardi R, Scartozzi M, Cardellino GG, Di Costanzo F, Rimassa L, Luporini AG, Longarini R, Zaniboni A, Bertolini A, Tomasello G, Pinotti G, Scagliotti G, Tortora G, Bonetti A, Spallanzani A, Frassineti GL, Tassinari D, Giuliani F, Cinieri S, Maiello E, Verusio C, Bracarda S, Catalano V, Basso M, Ciuffreda L, De Vita F, Parra HS, Fornaro L, Caporale M, de Braud F, Pietrantonio F.

BMC Cancer. 2019 Mar 29;19(1):283. doi: 10.1186/s12885-019-5498-3.

9.

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.

Crinò L, Bronte G, Bidoli P, Cravero P, Minenza E, Cortesi E, Garassino MC, Proto C, Cappuzzo F, Grossi F, Tonini G, Sarobba MG, Pinotti G, Numico G, Samaritani R, Ciuffreda L, Frassoldati A, Bregni M, Santo A, Piantedosi F, Illiano A, De Marinis F, Tamberi S, Giannarelli D, Delmonte A.

Lung Cancer. 2019 Mar;129:35-40. doi: 10.1016/j.lungcan.2018.12.025. Epub 2019 Jan 15.

PMID:
30797489
10.

Long-term therapy with bevacizumab in a young patient affected by NF-2: a case report and review of the literature.

Nigro O, Tartaro T, Tuzi A, Giaquinto A, Suter MB, Pinotti G.

Anticancer Drugs. 2019 Mar;30(3):318-321. doi: 10.1097/CAD.0000000000000732.

PMID:
30640792
11.

Rectovaginal fistula during treatment with axitinib in a patient with renal cell carcinoma: a case report and review of the literature.

Nigro O, Pastore A, Tartaro T, Bolzacchini E, Tuzi A, Pinotti G.

Anticancer Drugs. 2019 Apr;30(4):425-427. doi: 10.1097/CAD.0000000000000742.

PMID:
30640790
12.

Neuroendocrine Differentiation, Microsatellite Instability, and Tumor-infiltrating Lymphocytes in Advanced Colorectal Cancer With BRAF Mutation.

Digiacomo N, Bolzacchini E, Veronesi G, Cerutti R, Sahnane N, Pinotti G, Bregni M, Artale S, Verusio C, Crivelli F, Capella C, Sessa F, Furlan D.

Clin Colorectal Cancer. 2019 Jun;18(2):e251-e260. doi: 10.1016/j.clcc.2018.12.003. Epub 2018 Dec 20.

PMID:
30638691
13.

Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases.

Magnoli F, Bernasconi B, Vivian L, Proserpio I, Pinotti G, Campiotti L, Mazzucchelli L, Sessa F, Tibiletti MG, Uccella S.

Cancer Genet. 2018 Dec;228-229:28-40. doi: 10.1016/j.cancergen.2018.08.001. Epub 2018 Aug 28.

PMID:
30553470
14.

Isolated diaphragmatic metastasis from resected colorectal cancer.

Bolzacchini E, Tuzi A, De Palma D, Pinotti G.

Dig Liver Dis. 2019 Mar;51(3):454. doi: 10.1016/j.dld.2018.09.020. Epub 2018 Sep 27. No abstract available.

PMID:
30316786
15.

Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells.

Mortara L, Gariboldi MB, Bosi A, Bregni M, Pinotti G, Guasti L, Squizzato A, Noonan DM, Monti E, Campiotti L.

Target Oncol. 2018 Oct;13(5):657-665. doi: 10.1007/s11523-018-0586-x.

PMID:
30090970
16.

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT and TEXT Investigators and the International Breast Cancer Study Group.

N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4.

17.

Poorly Differentiated Neuroendocrine Carcinoma of the Sigmoid Tract in Long-Standing Ulcerative Colitis: Report of a Case and Review of the Literature.

Bolzacchini E, Chini C, Cortelezzi CC, Vallini I, Pinotti G, La Rosa S, Uccella S.

Int J Surg Pathol. 2018 Aug;26(5):479-483. doi: 10.1177/1066896917752443. Epub 2018 Jan 24. Review.

PMID:
29361862
18.

Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer.

Bolzacchini E, Tuzi A, Gobba S, Pinotti G.

J Thorac Oncol. 2017 Dec;12(12):e208-e210. doi: 10.1016/j.jtho.2017.08.023. No abstract available.

19.

Simultaneous Home Care project for frail advanced cancer patients: a model of integration between no profit and Public Health System.

Chini C, Bascialla L, Gobba S, Tuzi A, Tinelli G, Pomarico R, Giani N, Flore M, Reato S, Pinotti G.

Ann Oncol. 2017 Oct;28 Suppl 6:vi90. doi: 10.1093/annonc/mdx435.004. No abstract available.

20.

Screening of distress in hospitalized patients: the experience of medical oncology department.

Tinelli G, Chini C, Giaquinto A, Trotti E, Fabbro G, Angelonomi D, Vallini I, Pinotti G, Bellani ML.

Ann Oncol. 2017 Oct;28 Suppl 6:vi86-vi87. doi: 10.1093/annonc/mdx434.018. No abstract available.

21.

Response rate by molecular subtypes and p53 expression in neoadjuvant therapy for breast cancer with TAC regimen: a single-centre experience.

Marcon I, Vallini I, Bolzacchini E, Ritorna A, Giaquinto A, Pinotti G.

Ann Oncol. 2017 Oct;28 Suppl 6:vi38. doi: 10.1093/annonc/mdx424.047. No abstract available.

22.

Expression and clinical-pathological correlations of the androgen receptor (AR) in a series of ER and PgR negative breast cancers undergoing surgery: our center experience.

Ritorna A, Marcon I, Riva C, Giaquinto A, Vallini I, Pinotti G.

Ann Oncol. 2017 Oct;28 Suppl 6:vi31. doi: 10.1093/annonc/mdx424.020. No abstract available.

23.

Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study.

Cazzaniga M, Orlando L, Melegari E, Arcangeli V, Butera A, Pinotti G, Vallini I, Mocerino C, Giovanardi F, Cretella E, Gambaro A, Pistelli M, Donati S, Pizzuti L, Spagnuolo A, Putzu C, Leonardi V, De Angelis C, Pedroli S, Torri V.

Ann Oncol. 2017 Oct;28 Suppl 6:vi29. doi: 10.1093/annonc/mdx424.015. No abstract available.

24.

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT.

Regan MM, Walley BA, Francis PA, Fleming GF, Láng I, Gómez HL, Colleoni M, Tondini C, Pinotti G, Salim M, Spazzapan S, Parmar V, Ruhstaller T, Abdi EA, Gelber RD, Coates AS, Goldhirsch A, Pagani O.

Ann Oncol. 2017 Sep 1;28(9):2225-2232. doi: 10.1093/annonc/mdx285.

25.

Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.

Gobba S, Moccia AA, Gulden-Sala W, Conconi A, Diem S, Cascione L, Iacoboni G, Margiotta-Casaluci G, Aprile von Hohenstaufen K, Stathis A, Hitz F, Pinotti G, Gaidano G, Zucca E.

Hematol Oncol. 2018 Feb;36(1):84-92. doi: 10.1002/hon.2447. Epub 2017 Jun 16.

PMID:
28621491
26.

Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration.

Tuzi A, Bolzacchini E, Suter MB, Giaquinto A, Passaro A, Gobba S, Vallini I, Pinotti G.

J Thorac Dis. 2017 May;9(Suppl 5):S405-S409. doi: 10.21037/jtd.2017.04.09. Review.

27.

ALK-Rearranged Squamous Cell Carcinoma of the Lung Treated with Two Lines of ALK Inhibitors.

Bolzacchini E, Tuzi A, Pinotti G.

J Thorac Oncol. 2017 May;12(5):e55-e57. doi: 10.1016/j.jtho.2017.01.013. No abstract available.

28.

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Pettengell R, Salles G, Sebban C, Guillermo AL, Pinotti G, Devizzi L, Morschhauser F, Tilly H, Torri V, Hohaus S, Ferreri AJM, Zachée P, Bosly A, Haioun C, Stelitano C, Bellei M, Ponzoni M, Moreau A, Jack A, Campo E, Mazzucchelli L, Cavalli F, Johnson P, Thieblemont C.

J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29. Erratum in: J Clin Oncol. 2017 Jul 10;35(20):2342.

PMID:
28355112
29.

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.

Visco C, Chiappella A, Nassi L, Patti C, Ferrero S, Barbero D, Evangelista A, Spina M, Molinari A, Rigacci L, Tani M, Rocco AD, Pinotti G, Fabbri A, Zambello R, Finotto S, Gotti M, Carella AM, Salvi F, Pileri SA, Ladetto M, Ciccone G, Gaidano G, Ruggeri M, Martelli M, Vitolo U.

Lancet Haematol. 2017 Jan;4(1):e15-e23. doi: 10.1016/S2352-3026(16)30185-5. Epub 2016 Dec 5.

PMID:
27927586
30.

Response of Malignant Thymoma to Sorafenib.

Bolzacchini E, Chini C, Pinotti G.

J Thorac Oncol. 2016 Oct;11(10):e125-6. doi: 10.1016/j.jtho.2016.07.011. No abstract available.

31.

Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy.

Bolzacchini E, Marcon I, Bernasconi G, Pinotti G.

Dig Liver Dis. 2016 Aug;48(8):974. doi: 10.1016/j.dld.2016.04.002. Epub 2016 Apr 12. No abstract available.

PMID:
27158123
32.

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials.

Regan MM, Francis PA, Pagani O, Fleming GF, Walley BA, Viale G, Colleoni M, Láng I, Gómez HL, Tondini C, Pinotti G, Price KN, Coates AS, Goldhirsch A, Gelber RD.

J Clin Oncol. 2016 Jul 1;34(19):2221-31. doi: 10.1200/JCO.2015.64.3171. Epub 2016 Apr 4.

33.

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, Pinotti G, Gubiotti M, Cavazzini MG, Turazza M, Duranti S, De Simone V, Iezzi L, Bisagni G, Spazzapan S, Cavanna L, Saggia C, Bria E, Cretella E, Vici P, Santini D, Fabi A, Garrone O, Frassoldati A, Amaducci L, Saracchini S, Evangelisti L, Barni S, Gamucci T, Mentuccia L, Laudadio L, Zoboli A, Marchetti F, Bogina G, Lunardi G, Boni L.

PLoS One. 2015 Sep 25;10(9):e0139650. doi: 10.1371/journal.pone.0139650. eCollection 2015. No abstract available.

34.

Adult onset of ganglioneuroblastoma of the adrenal gland: case report and review of the literature.

Bolzacchini E, Martinelli B, Pinotti G.

Surg Case Rep. 2015 Sep 11;1:79. doi: 10.1186/s40792-015-0062-0. eCollection 2015 Dec.

35.

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, Pinotti G, Gubiotti M, Cavazzini MG, Turazza M, Duranti S, De Simone V, Iezzi L, Bisagni G, Spazzapan S, Cavanna L, Saggia C, Bria E, Cretella E, Vici P, Santini D, Fabi A, Garrone O, Frassoldati A, Amaducci L, Saracchini S, Evangelisti L, Barni S, Gamucci T, Mentuccia L, Laudadio L, Zoboli A, Marchetti F, Bogina G, Lunardi G, Boni L.

PLoS One. 2015 Sep 4;10(9):e0136731. doi: 10.1371/journal.pone.0136731. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139650.

36.

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA.

Lancet Oncol. 2015 Jul;16(7):848-58. doi: 10.1016/S1470-2045(15)00049-2. Epub 2015 Jun 16.

37.

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma.

Ceriani L, Martelli M, Zinzani PL, Ferreri AJ, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Gargantini L, Merli F, Pinotti G, Mannina D, Luminari S, Stathis A, Russo E, Cavalli F, Giovanella L, Johnson PW, Zucca E.

Blood. 2015 Aug 20;126(8):950-6. doi: 10.1182/blood-2014-12-616474. Epub 2015 Jun 18.

PMID:
26089397
38.

Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.

Rausei S, Lianos GD, Proserpio I, Ruspi L, Galli F, Frattini F, Mangano A, Rovera F, Boni L, Roukos DH, Pinotti G, Dionigi G.

Tumori. 2015 Sep-Oct;101(5):511-6. doi: 10.5301/tj.5000340. Epub 2015 Apr 22.

PMID:
25908036
39.

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group.

N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1.

40.

Multimodal treatment of gastric cancer.

Proserpio I, Rausei S, Barzaghi S, Frattini F, Galli F, Iovino D, Rovera F, Boni L, Dionigi G, Pinotti G.

World J Gastrointest Surg. 2014 Apr 27;6(4):55-8. doi: 10.4240/wjgs.v6.i4.55. Review.

41.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, Comella G, Amadori D, Pinto C, Carlomagno C, Nitti D, Daniele B, Mini E, Poli D, Santoro A, Mosconi S, Casaretti R, Boni C, Pinotti G, Bidoli P, Landi L, Rosati G, Ravaioli A, Cantore M, Di Fabio F, Aitini E, Marchet A; ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group.

Ann Oncol. 2014 Jul;25(7):1373-8. doi: 10.1093/annonc/mdu146. Epub 2014 Apr 12.

42.

Lymph node staging in gastric cancer: new criteria, old problems.

Rausei S, Dionigi G, Ruspi L, Proserpio I, Galli F, Tirotta F, Frattini F, Rovera F, Boni L, Pinotti G, Dionigi R.

Int J Surg. 2013;11 Suppl 1:S90-4. doi: 10.1016/S1743-9191(13)60025-4.

43.

Pyrosequencing for EGFR mutation detection: diagnostic accuracy and clinical implications.

Sahnane N, Gueli R, Tibiletti MG, Bernasconi B, Stefanoli M, Franzi F, Pinotti G, Capella C, Furlan D.

Diagn Mol Pathol. 2013 Dec;22(4):196-203. doi: 10.1097/PDM.0b013e3182893f55.

PMID:
24193003
44.

Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.

Ierardi AM, Floridi C, Fontana F, Chini C, Giorlando F, Piacentino F, Brunese L, Pinotti G, Bacuzzi A, Carrafiello G.

Radiol Med. 2013 Sep;118(6):949-61. doi: 10.1007/s11547-013-0968-1. Epub 2013 Jul 20.

PMID:
23892957
45.

Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011.

Rausei S, Dionigi G, Sano T, Sasako M, Biondi A, Morgagni P, Garofalo A, Boni L, Frattini F, D'Ugo D, Preston S, Marrelli D, Degiuli M, Capella C, Sacco R, Ruspi L, De Manzoni G, Roviello F, Pinotti G, Rovera F, Noh SH, Coit D, Dionigi R.

Ann Surg Oncol. 2013 Nov;20(12):3942-7. doi: 10.1245/s10434-013-3082-7. Epub 2013 Jul 10. Review.

PMID:
23838909
46.

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Crivellari D, Gray KP, Dellapasqua S, Puglisi F, Ribi K, Price KN, Láng I, Gianni L, Spazzapan S, Pinotti G, Lüthi JM, Gelber RD, Regan MM, Colleoni M, Castiglione-Gertsch M, Maibach R, Rabaglio M, Coates AS, Goldhirsch A.

Breast. 2013 Apr;22(2):130-137. doi: 10.1016/j.breast.2013.01.015. Epub 2013 Feb 28.

47.

A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel.

Maison-Blanche P, Vermorken JB, Goksel T, Machiels JP, Agarwala S, Rottey S, Daugaard G, Volovat C, Scheulen M, Sengeløv L, Grecea D, Eniu A, Jäger E, Meiri E, Cascinu S, Strumberg D, Demir G, Clemens M, Pinotti G, Nardi M, Guthrie T, Boelle E, Magherini E.

J Cardiovasc Pharmacol. 2013 Jun;61(6):495-504. doi: 10.1097/FJC.0b013e31828b73ff.

PMID:
23429593
48.

CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).

Mian M, Marcheselli L, Luminari S, Federico M, Cantonetti M, Sarris AH, Rossi A, Rambaldi A, Frontani M, Devizzi L, Gianni AM, Busetto M, Berti E, Martinelli G, Tsang RW, Ferreri AJ, Pinotti G, Pogliani E, Zucca E, Cortelazzo S.

Ann Hematol. 2011 Apr;90(4):401-8. doi: 10.1007/s00277-010-1083-1. Epub 2010 Sep 25.

PMID:
20872000
49.

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Scandurra M, Mian M, Greiner TC, Rancoita PM, De Campos CP, Chan WC, Vose JM, Chigrinova E, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Montes-Moreno S, Piris MA, Facchetti F, Tucci A, Nomdedeu JF, Lazure T, Lambotte O, Uccella S, Pinotti G, Pruneri G, Martinelli G, Young KH, Tibiletti MG, Rinaldi A, Zucca E, Kwee I, Bertoni F.

Br J Haematol. 2010 Nov;151(3):221-31. doi: 10.1111/j.1365-2141.2010.08326.x. Epub 2010 Aug 31.

PMID:
20813005
50.

Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.

Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, Casulli AF, Mannina D, Piro E, Pinotti G, Palmieri S, Catalano L, Callea V, Offidani M, Musto P, Bringhen S, Baldini L, Tosi P, Di Raimondo F, Boccadoro M, Palumbo A, Cavo M.

Eur J Haematol. 2010 Mar;84(3):223-8. doi: 10.1111/j.1600-0609.2009.01385.x. Epub 2009 Nov 23.

PMID:
19930441

Supplemental Content

Loading ...
Support Center